NCT04339348View on ClinicalTrials.gov

Comparative Safety and Efficacy of Vaginal Misoprostol Versus Lidocaine-prilocaine Cream in Levonorgestrel IUD Insertion

PHASE3CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

April 30, 2020

Primary Completion Date

February 1, 2021

Study Completion Date

March 1, 2021

Conditions
Contraception
Interventions
DRUG

vaginal misoprostol

vaginal misoprostol 200 mcg will be given 3 hours before LNG-IUD insertion plus inert placebo cream vaginally at the time of LNG-IUD insertion

DRUG

Lidocaine-Prilocaine Topical cream

Lidocaine-Prilocaine cream will be applied on the cervix at the time of LNG-IUD insertion plus vaginal placebo tablet 3 hours before LNG-IUD insertion

DRUG

placebo

inert placebo cream will be applied on the cervix at the time of LNG-IUD insertion plus vaginal placebo tablet 3 hours before LNG-IUD insertion

Trial Locations (1)

12511

Ahmedsamy, Giza

All Listed Sponsors
lead

Cairo University

OTHER

NCT04339348 - Comparative Safety and Efficacy of Vaginal Misoprostol Versus Lidocaine-prilocaine Cream in Levonorgestrel IUD Insertion | Biotech Hunter | Biotech Hunter